Overall, these findings suggest that CD151 dependency is associated with the ZEB1+/ERα+ status and that CD151 could be a promising target for inhibiting cell proliferation, migration, and invasion during partial EMT induced by ZEB1 in ERα+ breast cancer. Here, CD151 is linked to breast carcinoma.